In a recent genetic study, a CD74 polymorphism was associated with anti-TNF treatment failure in patients with IBD,40 generating the hypothesis that failure could be more likely to occur in the setting of defective CD74 signaling. Here, CD74 is linked to inflammatory bowel disease.